Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$13.18 +0.54 (+4.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) EBT Margin (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) posted EBT Margin of -135.56% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 36.04 percentage points from -99.52% a year earlier and down 59.31 percentage points from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) EBT Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT Margin at Enanta Pharmaceuticals was -96.74%, up 48.41 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at -127.90%, up 46.25 percentage points from FY2024.

  • Annual EBT Margin shows a five-year change of -99.31 percentage points (FY2020 to FY2025).
  • In prior fiscal years, Enanta Pharmaceuticals' EBT Margin was -174.15% in FY2024 (-8.76 pp), -165.39% in FY2023 (-23.57 pp), -141.82% in FY2022 (-30.99 pp) and -110.82% in FY2021 (-82.23 pp).
  • The fiscal Q3 2026 figure stands as the lowest quarterly EBT Margin since fiscal Q2 2025.
  • On a year-over-year basis, EBT Margin increased in six of the last eight quarters, with an average year-over-year change of +32.35 percentage points.
  • The strongest year-over-year quarter for EBT Margin in the past five years was fiscal Q2 2026, with a gain of 84.20 percentage points; the weakest was fiscal Q1 2022, with a drop of 72.44 percentage points.
  • According to Business Quant data, EBT Margin for the three prior fiscal quarters was -76.25% (Q2 2026), -64.00% (Q1 2026) and -123.42% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 26.66%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 25.18%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -4.11%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 29.63%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.19%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 27.53%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 41.75%
10 Enanta Pharmaceuticals 368.08 Mn -359.92 Mn - -135.56%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -135.56%
Mar 31, 2026 -76.25%
Dec 31, 2025 -64.00%
Sep 30, 2025 -123.42%
Jun 30, 2025 -99.52%
Mar 31, 2025 -160.45%
Dec 31, 2024 -133.89%
Sep 30, 2024 -199.81%
Jun 30, 2024 -128.28%
Mar 31, 2024 -184.82%
Dec 31, 2023 -189.02%
Sep 30, 2023 -155.91%
Jun 30, 2023 -184.44%
Mar 31, 2023 -211.37%
Dec 31, 2022 -123.04%
Sep 30, 2022 -129.62%
Jun 30, 2022 -165.03%
Mar 31, 2022 -179.48%
Dec 31, 2021 -109.05%
Sep 30, 2021 -141.65%
API Access

Enanta Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ENTA&period=max&api_key=YOUR_API_KEY